Top Markets
#1 Black Phoenix Black Phoenix +354.68%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +68.84%
#4 OpenEden OpenEden +62.66%
#5 Akedo Akedo +50.90%
#6 BasedHype BasedHype +26.50%
#7 Cryptopia Cryptopia +21.54%
#8 Avantis Avantis +20.20%
#9 Humanity Humanity +19.73%
#10 Ether.fi Ether.fi +17.74%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Cyxone AB (publ) Cyxone AB (publ)

Cyxone AB (publ)

CYXO
Classifica tra le azioni #40403
Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing... Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing innovative, disease-modifying therapies. Its primary therapeutic targets include rheumatoid arthritis, multiple sclerosis, and acute respiratory illnesses caused by viruses. The company's pipeline features Rabeximod, currently in Phase II clinical trials for both rheumatoid arthritis and COVID-19. Additionally, T20K, a drug candidate for multiple sclerosis, is undergoing Phase 1 evaluation. Established in 2015, the company is headquartered in Malmö, Sweden.
Prezzo delle azioni
$0.00162013
Ultima sincronizzazione: 2025-01-03
Capitalizzazione di mercato
$156.25K
Variazione (1 giorno)
0.36%
Variazione (1 anno)
0.00%
Paese
SE
Scambia Cyxone AB (publ) (CYXO)

Categoria

Healthcare
Rapporto P/B per Cyxone AB (publ) (CYXO)
Rapporto P/B al August 2026 TTM: 0.05
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Cyxone AB (publ), il rapporto P/B attuale (TTM) è 0.05. Alla fine del 2022, era pari a 0.95.
Storico del rapporto P/B per Cyxone AB (publ) da 2015 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
2026 (TTM) 0.05 -80.68%
2023 0.25 -73.81%
2022 0.95 -62.04%
2021 2.50 -27.47%
2020 3.45 49.69%
2019 2.31 74.16%
2018 1.32 -75.84%
2017 5.48 22.16%
2016 4.49 -98.16%
2015 243.41 0.00%
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 12,863.35%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 13,043.48%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 7,423.81%
BE